Cytokinetics CEO Robert I. Blum disposes of $490,950 in common shares
Blum exercised options for 7,500 shares at $10.60 and sold 7,500 shares at $65.46 on Sept. 28, 2026.
Blum exercised options for 7,500 shares at $10.60 and sold 7,500 shares at $65.46 on Sept. 28, 2026.